Forbion Growth Opportunities Fund I Cooperatief U.A.'s Form 4 filing
enGene Therapeutics Inc.ENGN ยท filed Oct 18, 2024
- Accession no.
- 0000950170-24-115607
- Filed
- Oct 18, 2024, 4:15 PM ET
- Trade date
- Dec 27, 2023-Oct 8, 2024
- Filing delay
- 296 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 13 non-derivative transactions. Open-market purchases total $3.01M. It was filed 296 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Forbion Growth Opportunities Fund I Cooperatief U.A.CIK 0001911047 | 10% Owner |
| Forbion Growth Management B.V.CIK 0001918318 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 27, 2023 | Common Shares | PPurchaseAcquired | +2,750 | $7.17F1 | +$19,711.45 | 2,002,750 | Direct | |
| Dec 28, 2023 | Common Shares | PPurchaseAcquired | +5,050 | $7.69F3 | +$38,826.93 | 2,007,800 | Direct | |
| Dec 29, 2023 | Common Shares | PPurchaseAcquired | +400 | $8.30 | +$3,320 | 2,008,200 | Direct | |
| Dec 29, 2023 | Common Shares | PPurchaseAcquired | +9,620 | $9.09F4 | +$87,450.61 | 2,017,820 | Direct | |
| Sep 27, 2024 | Common Shares | PPurchaseAcquired | +38,396 | $5.94F5 | +$228,010.81 | 2,056,216 | Direct | |
| Sep 27, 2024 | Common Shares | PPurchaseAcquired | +3,243 | $6.38F6 | +$20,688.39 | 2,059,459 | Direct | |
| Sep 30, 2024 | Common Shares | PPurchaseAcquired | +341,332 | $6.34F7 | +$2,163,362.22 | 2,400,791 | Direct | |
| Oct 1, 2024 | Common Shares | PPurchaseAcquired | +35,279 | $6.44F8 | +$227,157.95 | 2,436,070 | Direct | |
| Oct 2, 2024 | Common Shares | PPurchaseAcquired | +10,153 | $6.37F9 | +$64,696.95 | 2,446,223 | Direct | |
| Oct 3, 2024 | Common Shares | PPurchaseAcquired | +5,769 | $6.48F10 | +$37,396.97 | 2,451,992 | Direct | |
| Oct 4, 2024 | Common Shares | PPurchaseAcquired | +5,997 | $6.54F11 | +$39,241.97 | 2,457,989 | Direct | |
| Oct 7, 2024 | Common Shares | PPurchaseAcquired | +11,844 | $6.55F12 | +$77,530.82 | 2,469,833 | Direct | |
| Oct 8, 2024 | Common Shares | PPurchaseAcquired | +800 | $6.60F13 | +$5,278.48 | 2,470,633 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.10 to $7.37, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.48 to $8.19, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.65 to $9.39, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.31 to $6.30, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.31 to $6.40, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.97 to $6.60, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.30 to $6.60, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
- F9
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.07 to $6.67, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
- F10
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.435 to $6.585, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
- F11
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.50 to $6.62, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
- F12
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.42 to $6.60, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
- F13
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.59 to $6.60, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Referenced by the price of 1 transaction in Table I.